Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

New precertification requirement for OnpattroTM (patisiran)

August 17, 2018

As of August 10, 2018, the drug OnpattroTM (patisiran) requires precertification for all Independence commercial and Medicare Advantage members.

We are in the process of creating new medical policies for Onpattro. In the interim, requests for this drug will be evaluated in accordance with the manufacturer's prescribing information and the U.S. Food and Drug Administration labeling.

A comprehensive list of all drugs and services that require precertification is available online for Independence commercial members and Medicare Advantage members.


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.